AABB is instrumental in making biotherapies safe, effective and available worldwide.
The AABB biotherapies community is transforming patient care. We are driving policies to ensure patient access, expanding coverage for transformative therapies, advancing novel biotherapies research, and increasing the supply and safety of biological products. Together, this community is leading the discovery, development and delivery of innovative outcomes.
AABB represents expertise in quality management systems relevant to biotherapies. These efforts include consensus-based standards, accreditation, and novel qualification products.
AABB leads a wide range of professional development approaches designed to help members and the biotherapies community extend their knowledge and further their careers. Certification in Advanced Biotherapies represents significant achievement as a biotherapies professional.
Certified Advanced Biotherapies Professional (CABP) Credential
Becoming a CABP is a mark of distinction, establishing that qualified professionals have demonstrated – through a certification exam – that they have the necessary knowledge to credibly practice in the field of biotherapies.
AABB provides current information, resources and interpretive guidance for biotherapies professionals, patients and regulators. These efforts improve patient access and coordination of the field worldwide.
AABB supports a wide-range of innovative projects fueled by expert membership, partnerships and industry leadership engagement and recognition.
This unique industry membership offers a pivotal opportunity for biotherapies companies to deliver high-quality solutions – faster and at a lower cost. Accelerate your journey to market while profiting from AABB’s years of experience and vast education and networking opportunities.
Biotherapies use cells, living (bio) organisms, components of living organisms, substances derived from organisms, or laboratory-made versions of those substances to improve health, treat illness, or disease.
Biotherapies can be organized in a few general categories, though continued research and clinical studies will likely lead to future expansion and further innovative applications.
Connect with key audiences in the field while gaining access to AABB’s industry-leading community at their most attended event of the year. Limited connection packages and sponsorship opportunities available.
AABB, AATM to Host Cellular Therapies Webinar on Sept. 7
August 29, 2023
August 29, 2023
REGULATORY UPDATE: FDA Extends Comment Period for Draft Guidance on GCT Product Manufacturing
August 23, 2023
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
